| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,845 |
5,374 |
$1.52M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,847 |
3,513 |
$1.22M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,582 |
2,317 |
$1.01M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,336 |
4,918 |
$901K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
969 |
870 |
$542K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,686 |
2,962 |
$528K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,912 |
1,649 |
$480K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
626 |
523 |
$300K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,114 |
4,374 |
$247K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,799 |
4,856 |
$164K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,584 |
1,762 |
$152K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,568 |
3,663 |
$150K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,761 |
2,502 |
$136K |
| 71046 |
Radiologic examination, chest; 2 views |
4,547 |
3,932 |
$112K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,058 |
867 |
$101K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
985 |
595 |
$100K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,852 |
2,240 |
$78K |
| G0378 |
Hospital observation service, per hour |
133 |
103 |
$63K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,580 |
2,351 |
$45K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,441 |
1,492 |
$41K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
833 |
789 |
$37K |
| 80053 |
Comprehensive metabolic panel |
9,152 |
7,464 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
4,935 |
3,946 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,361 |
3,686 |
$23K |
| 73630 |
|
447 |
360 |
$21K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
58 |
50 |
$21K |
| 73562 |
|
423 |
358 |
$20K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
12 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
274 |
236 |
$15K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
73 |
61 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,111 |
2,284 |
$12K |
| Z7502 |
|
310 |
290 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,017 |
936 |
$11K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
418 |
203 |
$10K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
302 |
103 |
$9K |
| 73620 |
|
53 |
50 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
13 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,434 |
1,302 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,495 |
2,796 |
$6K |
| 99215 |
Prolong outpt/office vis |
50 |
45 |
$5K |
| 97161 |
|
124 |
113 |
$5K |
| 73610 |
|
89 |
79 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
60 |
58 |
$4K |
| 73030 |
|
78 |
65 |
$3K |
| 72100 |
|
13 |
12 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,170 |
7,805 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
668 |
630 |
$2K |
| 80061 |
Lipid panel |
719 |
677 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,688 |
1,400 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
18 |
16 |
$2K |
| 85610 |
|
3,421 |
2,979 |
$2K |
| 80320 |
|
1,365 |
1,248 |
$2K |
| 72110 |
|
15 |
13 |
$1K |
| 93017 |
|
16 |
15 |
$1K |
| 82553 |
|
2,865 |
2,289 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
490 |
464 |
$1K |
| 84484 |
|
3,964 |
3,082 |
$1K |
| 11721 |
|
42 |
39 |
$841.92 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,526 |
1,184 |
$794.47 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
220 |
204 |
$768.33 |
| 83690 |
|
2,340 |
2,080 |
$760.16 |
| 83735 |
|
4,143 |
3,201 |
$732.48 |
| 81003 |
|
1,956 |
1,784 |
$725.78 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
424 |
408 |
$630.40 |
| 82550 |
|
2,953 |
2,352 |
$572.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
896 |
769 |
$569.57 |
| 36415 |
Collection of venous blood by venipuncture |
12,358 |
9,415 |
$560.45 |
| 87070 |
|
446 |
342 |
$550.03 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
256 |
81 |
$460.02 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
706 |
673 |
$454.57 |
| 87430 |
|
816 |
779 |
$443.15 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
598 |
476 |
$438.33 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,772 |
1,685 |
$421.16 |
| 83880 |
|
646 |
545 |
$375.17 |
| 83605 |
|
1,361 |
1,213 |
$360.99 |
| 85730 |
|
2,091 |
1,886 |
$326.69 |
| 99201 |
|
14 |
13 |
$324.82 |
| 81001 |
|
3,741 |
3,376 |
$265.92 |
| J3490 |
Unclassified drugs |
1,757 |
1,045 |
$238.84 |
| 97164 |
|
12 |
12 |
$214.58 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,462 |
2,038 |
$203.48 |
| 85027 |
|
256 |
229 |
$201.29 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,672 |
2,348 |
$201.25 |
| 81025 |
|
801 |
744 |
$196.00 |
| 96376 |
|
108 |
70 |
$192.38 |
| 87088 |
|
287 |
259 |
$184.21 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
39 |
37 |
$158.64 |
| 87186 |
|
730 |
624 |
$143.66 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
744 |
659 |
$119.86 |
| 97010 |
|
1,385 |
404 |
$106.62 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
113 |
100 |
$101.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,281 |
1,126 |
$86.42 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
929 |
605 |
$83.47 |
| 84703 |
|
213 |
202 |
$72.76 |
| J2704 |
Injection, propofol, 10 mg |
493 |
434 |
$42.27 |
| 82150 |
|
176 |
154 |
$38.49 |
| 87040 |
|
116 |
103 |
$28.14 |
| 82803 |
|
89 |
72 |
$27.88 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
682 |
551 |
$26.90 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
108 |
88 |
$25.17 |
| 87420 |
|
140 |
137 |
$11.79 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
34 |
24 |
$5.01 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
24 |
24 |
$4.46 |
| J2060 |
Injection, lorazepam, 2 mg |
91 |
68 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15 |
15 |
$0.00 |
| 85379 |
|
38 |
36 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
84 |
66 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
18 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
42 |
37 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
68 |
52 |
$0.00 |
| 94760 |
|
34 |
30 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
20 |
12 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
18 |
14 |
$0.00 |
| 80305 |
|
48 |
42 |
$0.00 |
| 36600 |
|
26 |
24 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
93 |
85 |
$0.00 |
| 81002 |
|
52 |
45 |
$0.00 |
| 90714 |
|
13 |
13 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
17 |
15 |
$0.00 |